Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 159-164

  Fabrizi, F ^a,b   Lunghi, G ^a   Marai, P ^a   Marcelli, D ^a   Guarnori, I ^a   Raffaele, L ^a   Erba, G ^a   Pagano, A ^a   Locatelli, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b General Hospital   (Italy)

Author keywords

Aminotransferase levels; HCV genotyping; Renal allograft recipients; Serum HCV RNA

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY; LIVER ENZYME; VIRUS RNA;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS GENOME;

EID: 0030030027     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027033     Document Type: Article

References (40)

1. Anuras S, Piros J, Bonney W, Forker EL, Colville DS, Corry RJ Liver disease in renal transplant recipients. Arch Intern Med 1977; 137: 42
2. Debure A, Degos F, Pol S et al. Liver diseases and hepatic complications in renal transplant patients. Adv Nephrol 1988; 17: 375
3. Parfrey PS, Forbes RDC, Hutchinson TA, Kernick S, Farge D, Dauphinee WD. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610-615
4. Pirson Y, Alexander GPT, Van Ypersele de Strihou C. Long term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 1977; 296: 194-196
5. Ware AJ, Luby JP, Hollinger B et al. Etiology of liver disease in renal transplant patients. Ann Intern Med 1979; 91: 364-371
6. Chan TM, Lok ASF, Cheng IKP. Hepatitis C in renal transplant recipients. Transplantation 1991; 52: 810-813
7. Akpolat T, Arik N, Arinsoy T et al. High prevalence of antibodies to hepatitis C virus among renal transplant recipients: correlation with chronic liver dysfunction. (Letter) Nephron 1993; 64: 163-164
8. Fabrizi F, Marai P, Di Filippo S et al. Hepatitis C virus infection in kidney graft recipients (Letter). Nephrol Dial Transplant 1992; 7: 150
9. Fabrizi F, Marai P, Erba G et al. Hepatitis C virus infection in kidney graft recipients: a study with second-generation assays (Letter) Nephrol Dial Transplant 1992; 9: 1164-3165
10. Marcen R, Gomez C, Mateos ML et al. Hepatitis C antibody after kidney transplantation: clinical significance. Am J Nephrol 1993; 13: 184-189
11. Roth D, Fernandez JA, Burke GW, Esquenazy V, Miller J. Detection of antibody to hepatitis C virus in renal transplant recipients. Transplantation 1991; 51: 396-400
12. Ponz E, Campistol JM, Bruguera M et al. Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1994; 40: 748-751
13. Lau YNJ, Davis GL, Brunson ME et al. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993; 18: 1027-1031
14. Roth D, Zucker K, Cirocco R et al. The impact of hepatitis C virus infection on renal allosraft recipients. Kidney Int 1994; 45: 238-244
15. Goffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int 1994; 45: 551-555
16. McCruden EAB, Welch S, Batchelor B et al. Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients. J Med Virol 1994; 42: 158-163
17. Simmonds P, Holmes EC, Chan TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1994; 74: 2391-2399
18. Stuyver L, Van Arnhem W, Wyseur A, DeLeys B, Maertens G. Analysis of the putative E1 envelope and NS4 epitope regions of HCV type 3. Biochem Biophys Res Commun 1993; 192: 635-641
19. Chan SW, Simmonds P, McOmish F et al. Serological reactivity of blood donors with three different types of hepatitis C virus. Lancet 1991; 338: 1391
20. Yoshioka IC, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299
21. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon (Letter). Lancet 1992; 339: 1543
22. International Group. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914-919
23. Van Der Poel CL, Cuypers HT, Reesink HW et al. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet 1991; 337: 317-319
24. Garson JA, Tedder RS, Briggs M et al. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-1422
25. Ravaasi A, Primi D, Cariani E. Direct PCR amplification of HCV RNA from serum. PCR Meth Appl 1992; 1: 291-292
26. Prati D, Capelli C, Bosoni P, Mozzi F. Determination of HCV RNA in the serum by the Amplicor HCV PCR kit. Vox Sang 1994; 67: 112-114
27. Stuyver L, Rossau R, Wyseur A et al. Typing of HCV isolates and characterization of new (sub)types using a line probe assay. J Gen Virol 1993; 74: 1093-1102
28. Fabrizi F, Raffaele L, Bacchini G et al. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Nephrol Dial Transplant 1993; 8: 744-747
29. Fabrizi F, Marcelli D, Bacchini G, Guarnori I, Erba G, Locatelli F. Antibodies to hepatitis C virus (HCV) in chronic renal failure patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994; 9: 780-784
30. Alter MJ, Hadler SC, Judson FN et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231-2235
31. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905
32. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-724
33. Fabrizi F, Lunghi G, Guarnori I et al. Virological characteristics of hepatitis C virus (HCV) infection in chronic haemodialysis patients: a cross-sectional study. Clin Nephrol (in press)
34. DuBois D, Gretch D, Dela Rosa C et al. Quantitation of hepatitis C viral RNA in our hemodialysis patients: gender-related differences in viral load. Am J Kidney Dis 1994; 24: 795-801
35. Alberti A, Morsica G, Chemello L et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697-698
36. Okamoto H, Kurai K, Okada SI et al. Full-length sequences of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331-341
37. Chan SW, McOmish F, Holmes EC et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-1141
38. Pistello M, Maggi F, Vatteoni L, Cecconi N, Panicucci F. Prevalence of HCV genotypes in Italy. J Clin Microbiol 1994; 32: 232-234
39. Ravaggi A, Zonaro A, Marin MG, Puoti M, Cariani E. Distribution of viral genotypes in Italy determined by HCV typing by DNA immunoassay. J Clin Microbiol 1994; 32: 280-284
40. Pozzato G, Kaneko S, Moretti L et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291-296